logo-large
  • Browse Categories

Publications by authors named "Jessica R Carter"

Claim this Profile
C
CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter].
Gisela M Vaitaitis, Michael H Olmstead, Dan M Waid, Jessica R Carter, David H Wagner

Diabetologia· September 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.
Gisela M Vaitaitis, Michael H Olmstead, Dan M Waid, Jessica R Carter, David H Wagner

Diabetologia· November 2014


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
Dan M Waid, Teri Schreiner, Gisela Vaitaitis, Jessica R Carter, John R Corboy

J Neuroimmunol· May 2014


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.
Gisela M Vaitaitis, Jessica R Carter, Dan M Waid, Michael H Olmstead, David H Wagner

J Immunol· July 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: